Transforming HIV
Our efforts span the full continuum of HIV care – from prevention to treatment to working toward the ultimate goal: a cure. Beyond the science, we partner with like-minded stakeholders to contribute ending HIV as a global public health threat by 2030.
Chronic Hepatitis
With the same tenacity, innovation and focus that drove our work in HIV, we relentlessly work to address the needs and transform care for people with chronic hepatitis.
Treating the COVID-19 Public Health Crisis
We are committed to tackling the COVID-19 pandemic, applying our deep antiviral knowledge and relentless innovation. We are studying ways to enhance the disruption of viral replication advancing novel treatments to help more people.
stopthevirus.eu provides information on Gilead engagement in the health policy landscape regarding communicable diseases. It features policy recommendations and reports from Gilead’s activities across Europe.
Gilead has been, is, and will be here to fight alongside policymakers, nurses, clinicians and campaigners to address the outstanding challenges in the field of virology. Without relentless collaboration and partnership, we could not have come this far.
At Gilead we believe that the impossible is not impossible. It’s what’s next.
This website has been created by Gilead for the purposes of disease education and awareness.
As we mark the 40th anniversary since the first cases of AIDS were reported, it is time for reflection; since the start of the epidemic around 84.2 million people have acquired HIV and around 40.1 million people have died of AIDS-related illnesses1.
This website has been created by Gilead for the purposes of disease education and awareness.
Since the start of the epidemic around 84.2 million people have acquired HIV and around 40.1 million people have died of AIDS-related illnesses1 .
This website has been created by Gilead for the purposes of disease education and awareness.
During the Sidaction 2021 conference1 (March 2021), Françoise Barré-Sinoussi (winner of the French Nobel prize for Medicine, 2008), the leading scientist responsible for the co-discovery of HIV, expressed her concerns about the impact of the COVID-19 global health crisis on the HIV epidemic, saying “We could lose years of progress achieved in tackling HIV” 2.
This website has been created by Gilead for the purposes of disease education and awareness.
The HIV landscape has rapidly evolved over the course of the last 40 years. Today, HIV has largely become a manageable condition and people living with HIV can expect to live nearly as long as the general population1.
This website has been created by Gilead for the purposes of disease education and awareness.
At the height of the HIV pandemic in the mid-1990s, mental health was not a priority. As the virus spread and the death toll climbed, attention centred on understanding the disease and stopping its spread. Promoting preventative measures and the hunt for effective management of HIV infection absorbed the energy and resources of a community faced with a global crisis that had a personal impact on millions.
This website has been created by Gilead for the purposes of disease education and awareness.
Blood-borne viruses include HIV and viral hepatitis B and C viruses, all of which people may carry in their blood and spread by various routes. These viruses are a public health challenge across the world, including in Europe.
This website has been created by Gilead for the purposes of disease education and awareness.
Over the past thirty years, coordinated efforts of key stakeholders and treatment innovation have transformed HIV from a fatal condition into a manageable long-term condition1. Today people living with HIV can have a near-normal life expectancy.
This website has been created by Gilead for the purposes of disease education and awareness.
Over the past 12 months, Gilead Sciences has partnered with POLITICO Europe on a journalistic investigation into HIV called “Telescope: the new AIDS epidemic”.
This website has been created by Gilead for the purposes of disease education and awareness.
In an effort to fight the HIV epidemic globally, the International Association of Providers of AIDS Care IAPAC, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Human Settlements Programme (UN-Habitat) and the City of Paris, joined forces in 2014 and endorsed the Paris Declaration.
This website has been created by Gilead for the purposes of disease education and awareness.
Gilead Sciences Germany is committed to supporting national efforts to contain and ultimately end the HIV epidemic once and for all. Together with partner organizations, Gilead intends to build on the progress achieved so far, to accelerate the fight against HIV, while at the same time supporting people with HIV to live well at every stage of life.
You are now leaving www.stopthevirus and visiting a new site which is not owned or controlled by Gilead Sciences Europe. Gilead Sciences Europe is therefore not responsible for your interactions with the website or the information it provides.
Cancel Follow link